January 17, 2017 / 7:09 AM / 3 years ago

BRIEF-Allergan and Gedeon Richter announce positive phase III results for Ulipristal Acetate 5 and 10 MG in treatment of Uterine Fibroids

Jan 17 (Reuters) - Allergan Plc :

* Allergan and Gedeon Richter announce positive phase III results for Ulipristal Acetate 5 and 10 MG in treatment of Uterine Fibroids

* Says a new drug application filing for Ulipristal Acetate is planned for second half of 2017

* Allergan - says study met all co-primary and secondary endpoints with both treatment arms achieving statistically significant results over placebo

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below